Correlation Between DongKook Pharmaceutical and NeoPharm

Can any of the company-specific risk be diversified away by investing in both DongKook Pharmaceutical and NeoPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DongKook Pharmaceutical and NeoPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DongKook Pharmaceutical Co and NeoPharm LTD, you can compare the effects of market volatilities on DongKook Pharmaceutical and NeoPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DongKook Pharmaceutical with a short position of NeoPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of DongKook Pharmaceutical and NeoPharm.

Diversification Opportunities for DongKook Pharmaceutical and NeoPharm

0.69

Correlation Coefficient

DongKook Pharmaceutical  NeoPharm

Poor diversification

The 3 months correlation between DongKook and NeoPharm is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding DongKook Pharmaceutical Co and NeoPharm LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeoPharm LTD and DongKook Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DongKook Pharmaceutical Co are associated (or correlated) with NeoPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeoPharm LTD has no effect on the direction of DongKook Pharmaceutical i.e., DongKook Pharmaceutical and NeoPharm go up and down completely randomly.

Pair Corralation between DongKook Pharmaceutical and NeoPharm

Assuming the 90 days trading horizon DongKook Pharmaceutical Co is expected to under-perform the NeoPharm. But the stock apears to be less risky and, when comparing its historical volatility, DongKook Pharmaceutical Co is 1.4 times less risky than NeoPharm. The stock trades about -0.01 of its potential returns per unit of risk. The NeoPharm LTD is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,127,500  in NeoPharm LTD on September 20, 2024 and sell it today you would earn a total of  72,500  from holding NeoPharm LTD or generate 6.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

DongKook Pharmaceutical Co  vs.  NeoPharm LTD

DongKook Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DongKook Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, DongKook Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

NeoPharm LTD

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeoPharm LTD are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, NeoPharm may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with DongKook Pharmaceutical and NeoPharm

The main advantage of trading using opposite DongKook Pharmaceutical and NeoPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DongKook Pharmaceutical position performs unexpectedly, NeoPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoPharm will offset losses from the drop in NeoPharm's long position.

The idea behind DongKook Pharmaceutical Co and NeoPharm LTD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.